YTHDF1 and hepatocellular carcinoma: For example, HIF-1α was found to not only promote the glycolytic process but also enhance the expression of YTHDF1/2 in hepatocellular carcinoma (HCC) and lung squamous cell carcinoma (LUSC), respectively, leading to cancer cell spread [66–68].